Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHill & Smith Regulatory News (HILS)

Share Price Information for Hill & Smith (HILS)

Share Price is delayed by 15 minutes
Get Live Data
2,865.00    -10.00 (-0.35%)
Bid:
2,870.00
Ask:
2,875.00
Spread: 5.00 (0.174%)
Market Cap: £2.24b
HILS Live PriceLast checked at - London Stock Exchange

Intraday Hill & Smith Share Chart

Director/PDMR Shareholding

27 May 2026 15:01

RNS Number : 9325F
Hill & Smith PLC
27 May 2026
 

 

Hill & Smith PLC

(the 'Company' or 'Hill & Smith')

 

Director / PDMR Shareholding

 

Hill & Smith announces that on 26 May 2026, it was notified of the exercise and subsequent sale by Chris McLeish, Chief Financial Officer of Shares under his 2023 Deferred Bonus Buy-Out Award.

 

The Notification of Dealing Form can be found below:

 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Chris McLeish

2.

Reason for the notification

(a)

Position/status

Chief Financial Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.1

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary Shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Acquisition of Ordinary Shares pursuant to the exercise of an award under his 2023 Deferred Bonus Buy-Out Award.

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

 

5,690

(e)

Aggregated information

N/A

- Aggregated volume

- Price

(f)

Date of the transaction

26 May 2026

(g)

Place of the transaction

Outside of a trading venue

4.2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary Shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Sale of Ordinary Shares to cover tax and NI liability on the exercise of awards outlined in 4.1.

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

£27.60

 

2,682

(e)

Aggregated information

N/A

- Aggregated volume

- Price

(f)

Date of the transaction

26 May 2026

(g)

Place of the transaction

XLON

 

Enquiries:

 

Karen Atterbury

Company Secretary

0121 704 7430

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHAKOBKQBKDKPB
Date   Source Headline
12th Mar 20241:35 pmRNSDirector/PDMR Shareholding
12th Mar 20247:15 amRNSAcquisition of FM Stainless
12th Mar 20247:00 amRNSFull Year Results
1st Mar 20249:20 amRNSTotal Voting Rights
2nd Feb 202412:13 pmRNSHolding(s) in Company
1st Feb 20249:33 amRNSTotal Voting Rights
30th Jan 20247:00 amRNSBoard Appointment - Chief Operating Officer
22nd Jan 202410:22 amRNSBlock listing Interim Review
22nd Jan 20249:31 amRNSHolding(s) in Company
9th Jan 20247:00 amRNSAcquisition of Capital Steel
2nd Jan 202411:29 amRNSTotal Voting Rights
2nd Jan 20249:59 amRNSTransaction in Own Shares
22nd Dec 202312:00 pmRNSTransaction in Own Shares
21st Dec 20237:00 amRNSBoard Appointment
4th Dec 20238:36 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSComposites Investor Seminar
22nd Nov 20232:24 pmRNSDirector Appointment
17th Nov 20237:00 amRNSAcquisition of United Fiberglass
14th Nov 20237:00 amRNSTrading update
1st Nov 20238:29 amRNSTotal Voting Rights
28th Sep 20237:53 amRNSDirector/PDMR Shareholding
1st Sep 202310:21 amRNSTotal Voting Rights
10th Aug 20237:57 amRNSDirector/PDMR Shareholding
1st Aug 20238:06 amRNSTotal Voting Rights
21st Jul 20239:30 amRNSBlock listing Interim Review
19th Jul 20231:38 pmRNSConfirmation of Directorate Change at AGM
3rd Jul 202310:27 amRNSTotal Voting Rights
14th Jun 20233:11 pmRNSHolding(s) in Company
1st Jun 20234:39 pmRNSTotal Voting Rights
30th May 20237:00 amRNSDirector/PDMR Shareholding
25th May 20231:51 pmRNSResult of AGM
25th May 20237:00 amRNSDirectorate Change
25th May 20237:00 amRNSTrading update
22nd May 20238:50 amRNSHolding(s) in Company
3rd May 202311:44 amRNSTotal Voting Rights
17th Apr 20233:44 pmRNSHolding(s) in Company
12th Apr 202311:02 amRNS2022 Annual Report and Notice of 2023 AGM
3rd Apr 202312:43 pmRNSTotal Voting Rights
22nd Mar 20233:54 pmRNSDirector/PDMR Shareholding
13th Mar 20233:25 pmRNSDirector/PDMR Shareholding
10th Mar 20231:26 pmRNSDirector/PDMR Shareholding
8th Mar 202312:12 pmRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSPreliminary Results
8th Mar 20237:00 amRNSAcquisition of Korns Galvanizing
1st Mar 20238:10 amRNSTotal Voting Rights
20th Feb 20237:00 amRNSAcquisition of Enduro Composites
1st Feb 20238:51 amRNSTotal Voting Rights
27th Jan 20238:29 amRNSHolding(s) in Company
25th Jan 20233:16 pmRNSHolding(s) in Company
25th Jan 20237:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.